mail
versión imprimible
 
 

2nd Next-Generation Conjugates Summit

Evvnt Promotion / evvnt
-
21.02.2023 - 23.02.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 to 17:00
 
Temas de la conferencia
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1400588-3?pid=4832

Speakers: Christian Marsolais, Senior Vice President and Chief Medical Officer, Theratechnologies Inc., Fu-An Kang, Vice President, Research, MiRecule Inc., and more
 

Información e inscripción:

https://go.evvnt.com/1400588-2?pid=4832
Ms. Jessica Durston
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developer Pricing - Conference + Workshop Day: USD 4197.00, Drug Developer Pricing - Conference Only: USD 2999.00, Service Provider Pricing - Conference + Workshop Day: USD 4997.00, Service Provider Pricing - Conference Only: USD 3599.00
Los participantes esperaban
1000 - 1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärzte der WeltAMREF - African Medical and Research FoundationÄrztekammer für WiennewTreeHelix - Forschung & Beratung WienÖsterreichische Akademie der ÄrzteÖsterreichische Gesellschaft für Public Health